N,N - (Dithiobis-2,1-Ethanediyl)Di[2,5-Dichlorobenzenesulfonamide](CAS 927822-86-4)
| Purity | Grade | Package | Stock | Price | Quantity |
| 98% | RG | 25MG | In Stock | 38 USD
|
|
| 98% | RG | 100MG | In Stock | 113 USD
|
|
| 98% | RG | 250MG | In Stock | 225 USD
|
|
| 98% | RG | 1G | In Stock | 564 USD
|
|
|
|||||
Available NMR Spectrum
Verified In Stock
Fast Shipping ISO 9001
Quality System
Physical and chemical properties of 927822-86-4
Acidity coefficient |
9.26±0.50(Predicted) |
|---|---|
Appearance of Characters |
white solid |
Boiling Point |
708.8±70.0 °C at 760 mmHg |
Density |
1.6±0.1 g/cm3 |
Exact Mass |
567.874695 |
Flash Point |
382.5±35.7 °C |
Index of Refraction |
1.643 |
LogP |
6.39 |
Molecular Formula |
C16H16Cl4N2O4S4 |
Molecular Weight |
570.381 |
PSA |
159.70000 |
Solubility |
DMSO: soluble20mg/mL, clear |
Stability |
Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 1 month. |
Storage condition |
-20℃ |
Vapour Pressure |
0.0±2.3 mmHg at 25°C |
Download COA of 927822-86-4
Spectrums of 927822-86-4
1.The NMR spectrum displayed on the page is a pre-sale reference spectrum and may differ from that of the actual received batch.
2.The accompanying documentation will include the NMR spectrum and purity analysis data for the shipped batch.
Download SDS of 927822-86-4
Pictograms |
![]() |
|---|---|
Signal Word |
Warning |
Hazard Statements |
H315 Causes skin irritation H319 Causes serious eye irritation H335 May cause respiratory irritation |
Safety Data Sheet |
Q&A for CAS 927822-86-4
1. How can I verify product quality?
Every batch is tested in accordance with ISO 9001 requirements. We provide a Certificate of Analysis (COA), NMR spectrum, purity report, and test methods with each shipment. Third-party retesting is supported, and we offer a full refund if our data is incorrect.
2. What is the delivery time?
Orders are shipped on the second business day via FedEx, DHL, or UPS. International deliveries typically arrive within 7 business days (subject to customs clearance).
3. What if the received product doesn’t meet quality standards?
If the product does not match the COA or has a quality issue, we will issue a full refund or replacement upon verification.
4. Are hazardous labels included? How is safe shipping ensured?
Hazardous products are labeled and packaged in compliance with international regulations and shipped with an up-to-date Safety Data Sheet (SDS) to ensure safe and compliant transport.
5. Do you offer technical support?
Yes. Our technical team is available to assist with questions about product use, storage, purity requirements, applications, and more.
6. Are volume discounts available?
Yes. We offer competitive pricing for bulk orders. Please submit a quotation request, and we’ll provide a customized offer.
7. Do you provide samples?
Yes, samples are available for select products for testing and validation. Please submit a sample request or contact our sales team to confirm availability and specifications.
8. Do you have products in stock?
Items marked “In Stock” on our website are ready for immediate shipment, usually within 1–2 business days. Large packs or custom specifications require lead time confirmation.
9. Can you customize purity or packaging?
Yes. We support customization of purity, packaging size, and special testing requirements. Please share your detailed needs, and we’ll provide a solution.
10. Is the COA consistent with the shipped batch?
Yes. The COA provided with your shipment matches the actual batch and includes the batch number. COAs shown online are for reference or from previous batches.
11. Do you support long-term supply agreements?
Yes. We offer stable batch consistency, pricing agreements, and safety stock options for long-term customers to ensure uninterrupted supply.
12. What payment methods do you accept?
We accept bank transfer (T/T), PayPal, and other methods. Credit terms may be available for qualified long-term partners.
Applications of 927822-86-4
KC7F2 has potential applications in:
- Cancer Therapy: Its primary application is as an anticancer agent targeting tumors that exhibit hypoxia, which is common in solid tumors such as gliomas and breast cancers.
- Retinopathy Treatment: Recent studies suggest its efficacy in treating retinal neovascularization by inhibiting the HIF-1α vascular endothelial growth factor pathway, showing promise for conditions like retinopathy of prematurity.
Operate under the ISO 9001 system

